← Back to Search

Personalized, Transdiagnostic Assessments for Mental Illness

N/A
Waitlist Available
Led By Michael K Owens
Research Sponsored by Introspect Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks
Awards & highlights
No Placebo-Only Group

Summary

This study is investigating the self-report adherence and assessment completion rates when presented with a transdiagnostic, partial assessment multiple times a day when compared with a monotopic, complete assessment once a day. Specifically, the investigators are testing the hypothesis that the personalization of diagnostic assessment topics and timing will lead to improved self-report regiment adherence rates, assessment completion rates, and total assessments completed during the study period. The study does not test the efficacy of the personalized assessments as a diagnostic instrument, there is no clinical decision support provided to clinicians during this study, and there is no treatment provided during this study.

Eligible Conditions
  • Mental Illness
  • Mental Health
  • Delivery of Health Care
  • Self-Assessment
  • Mental Health Diagnosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Assessment Questions Scored
Completed Assessments Scored
Self-Report Adherence Rate
Secondary study objectives
Assessment Completion Rate
Response Time
Time per Assessment Question

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Personalized, Transdiagnostic AssessmentsExperimental Treatment1 Intervention
One or more times per day, participants in the Experimental Arm will be presented with a variable-length assessment based on the personalization algorithm. The assessment will include a dynamic number of questions based on personalized relevancy, engagement level, and assessment completion metrics. Questions are scored immediately upon submission, regardless of how many questions are answered. As questions are scored, the personalization algorithm takes the previous responses and response times into consideration when determining what and when to ask additional questions.
Group II: Monotopic AssessmentsActive Control1 Intervention
Once daily, participants in the Control Arm will be presented with the standard of care mental health surveillance assessments identified as relevant upon intake. The assessments will be scored in totality or not at all and have a fixed, predefined number of questions. No personalization of assessment will take place.

Find a Location

Who is running the clinical trial?

Introspect HealthLead Sponsor
Michael K OwensPrincipal InvestigatorIntrospect Health
Anne M Huffman, PhDStudy DirectorCalifornia Institute of Integral Studies
~8 spots leftby Nov 2025